Harry Erba

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.

A study co-led by DCI researcher Harry P. Erba, MD, PhD, demonstrated that quizartinib plus chemo doubled AML survival time.

“This is really the thing we look forward to all year and we weren’t going to let the pandemic get in the way this year,” said DCI exec. director Michael Kastan, MD, PhD.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

Join faculty speakers from the DCI Hematologic Malignancies & Cellular Therapy Disease Group on Oct. 5 for a virtual OncLive summit on leukemia & lymphoma.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Harry Erba, MD, PhD, David Rizzieri, MD, and Thomas LeBlanc, MD, discuss the benefits of therapy for the great majority of older acute myeloid leukemia patients.

DCI blood cancer researchers shared new scientific discoveries and treatments in lymphomas, leukemias, and multiple myeloma at OncLive summit.